Deprescribing Antipsychotics: a Multiple Case Study
This study is recruiting. It focuses on schizophrenia and currently lists participation information in France.
In Strasbourg
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on schizophrenia and currently lists participation information in France.
In StrasbourgThis study is recruiting in the United States. It is testing BXCL501 for schizophrenia.
Multiple locations, including AnaheimThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.
Multiple locations, including BirminghamThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Taiwan.
In TaipeiThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Indonesia.
In IndonesiaThis study is recruiting. It focuses on depression and currently lists participation information in China.
In BeijingThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Belgium.
In BelgiumThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In BostonThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Egypt.
In EgyptThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Italy.
In Italy